Understanding Pharmacy Benefit Managers And Their Importance

PBMs are critical players in the healthcare industry. This article explains their role, services, and why they matter.

Hospice Pharmacy benefit managers are third-party administrators that work with Hospices and other payers to manage prescription drug benefits for their members. They negotiate with drug manufacturers and pharmacies on behalf of their clients to obtain the best possible prices for prescription drugs.

Hospice PBMs play a critical role in the healthcare system by helping to control drug costs and ensure that patients have access to the medications they need. They also provide important services such as developing formularies (lists of drugs that are covered by an insurance plan), processing claims, and providing clinical support and other tools to help patients manage their medications.

There are several reasons why PBMs matter

Cost containment

PBMs are often able to negotiate better prices for prescription drugs than individual insurers or consumers would be able to on their own. They can use their collective bargaining power to negotiate discounts and rebates from drug manufacturers, and they can steer patients toward lower-cost generic drugs or preferred brands.

Access to medication

PBMs can help ensure that patients have access to the medications they need by negotiating with pharmacies and manufacturers to ensure that drugs are available at an affordable price. PBMs also work to prevent drug shortages and can help patients find alternative treatments if a particular drug is not available.

Clinical support

PBMs can provide clinical support to help patients manage their medications, including tools to help patients stay on track with their prescriptions, identify potential drug interactions or side effects, and get access to other healthcare resources.

Overall, PBMs can play a critical role in helping to control healthcare costs, improve access to medication, and provide important clinical support for patients.

Pharmacy benefit managers are organisations engaged by health plans, large corporations, unions, and government agencies to handle prescription medication benefits programmes.

PBMs can be viewed as middlemen. The patient's insurance company hires them to coordinate the delivery and selling of prescriptions to the drugstore. The pharmacy provides the medications to the patients, while the PBM reimburses the pharmacy for filling the prescription.

Initially intended to process claims on behalf of clients, PBMs initially filled a necessary niche. In theory, the collective purchasing power of pharmacy benefit manager companies, which represent consumers from multiple insurers and employers, would reduce health care costs and be passed on to consumers.

Pharmacy benefit managers are expected to leverage their management tools, pricing concessions, and formulary clout for the advantage of the insurers they represent, who are then expected to pass on the savings to their own consumers in the form of improved benefits and lower premiums.

But as PBMs grew larger and more profit-driven as publicly traded firms with stockholders, insurers never saw decreased costs. With mergers and acquisitions, three giant PBMs — CVS, Express Scripts, and UnitedHealth's Optum — now account for more than 70 percent of the nation's drug benefit claims. In spite of this consolidation, prices have soared.

In 1986, prescription drug benefits in the United States cost $26.8 billion dollars. According to the most cautious forecasts, this amount will surpass $320 billion by 2016, representing a rise of over 1,000 percent. Throughout the same time period, the average patient out-of-pocket expense for drug benefits has climbed by more than 170 percent.

PBMs have been able to flourish by utilising fees, rebate schemes, and spread cost strategies. Yet, they have not been able to improve service to patients or reduce costs for insurers.

Pharmaceutical benefit managers earn from the system through the service fees they bill insurers. Recently, though, PBMs' reliance on rebates and spread pricing has attracted increased scrutiny.

PBMs have been accused of selecting medications for their formulary lists based on rebates rather than the best value (efficiency and cost). For instance, if a drug costs $100 and offers the PBM a $50 rebate (which the PBM is permitted to keep), it is more likely to be picked for usage by the PBM than a prescription that provides the same advantages for a total cost of $20 with no rebate.

Spread pricing occurs when pharmacy benefit managers are reimbursed by health insurers for a greater price for generic pharmaceuticals than they actually pay pharmacies for these drugs, and then pocket the difference. The payments that pharmacy benefit managers (PBMs) generate for pharmacies are kept hidden from health plans. If a PBM pays a pharmacy $10 to fill a prescription, but the pharmacy charges the health plan $50 to complete the prescription, the PBM would pocket the difference.

License: You have permission to republish this article in any format, even commercially, but you must keep all links intact. Attribution required.